Ketotifen Vaginal Gel

The images above are shown for illustration purposes only. They may not be an exact representation of the product.

Ketotifen Vaginal Gel

Home » Pharmacy » Ketotifen Vaginal Gel

Ketotifen is a medication considered by many prescribers for people dealing with ongoing allergies, asthma or MCAS.

“Ketotifen is defined as an antiallergic drug that inhibits the release of vasoactive substances from mast cells, stabilizes mast cells, and exhibits antihistaminic effects, making it effective for conditions like asthma and atopic dermatitis.”

Source: Pharmacology, Toxicology and Pharmaceutical Science

In research, Ketotifen’s influence goes beyond the common culprit histamine. Ketotifen is one of the few medications that may offer both immediate symptom relief (antihistamine) and long-term control (mast cell stabilization)—making it desirable, especially for patients with:

Chronic allergic conditions
Mast Cell Activation Syndrome (MCAS)
Complex hypersensitivity reactions
Inflammatory allergic disorders not responding to standard therapies

Read more: Ketotifen: Mast Cell Stabilizer for Mast Cell Activation Syndrome and Allergy Symptoms

This medication requires a prescription.

Additional Information

Ketotifen Vaginal Gel is a compounded formulation prepared by HDRx according to individualized prescriber specifications. A valid prescription from a licensed healthcare provider is required.

Ketotifen is described in pharmacology literature as an antiallergic medication with antihistamine activity and mast cell–stabilizing properties. These mechanisms are discussed in clinical contexts involving immune responses, hypersensitivity reactions, and mast cell activity.

Compounded vaginal gel formulations allow healthcare providers to request specific strengths and delivery bases tailored to individualized care plans. Compounding may support localized application when a provider determines that a customized formulation is appropriate.

In research and clinical discussions, ketotifen has been referenced in connection with mast cell–related responses and complex hypersensitivity conditions. Providers sometimes evaluate compounded ketotifen when developing individualized strategies for patients experiencing mast cell activity in sensitive tissues.

To learn more about ketotifen and mast cell stabilization, visit our ketotifen compounding page, explore our article on compounded ketotifen and mast cell activation syndrome, and read about mast cell stabilizers used in compounding pharmacy practice.

Compounded medications are not FDA-approved and are prepared to meet specific patient needs as directed by a licensed healthcare provider. Patients should consult their prescriber to determine whether this formulation is appropriate for their individual care plan.

The formulas and/or statements listed are provided for educational purposes only. They are compounding ideas that have commonly been requested by physicians, and have not been evaluated by the Food and Drug Administration. Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.